Metabolic Syndrome in Children and Adolescents Living with HIV

Autor: Espiau M, Yeste D, Noguera-Julian A, Gonzalez-Tome MI, Falcon-Neyra L, Gavilan C, Navarro-Gomez ML, Mellado-Pena MJ, Gracia-Casanova M, Colino-Gil ME, Mendez M, Ciria Calavia LM, Fortuny C, Carrascosa A, Soler-Palacin P

Publikováno v: PEDIATRIC INFECTIOUS DISEASE JOURNAL
r-FSJD. Repositorio Institucional de Producción Científica de la Fundació Sant Joan de Déu
instname
r-FISABIO. Repositorio Institucional de Producción Científica

Background: Metabolic syndrome (MetS) is considered an independent risk factor for developing cardiovascular disease. It is well known that the prevalence of metabolic disorders have increased in pediatric HIV-infected children. The objective of this

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::15971243abaad24cf2faf54472d3d0d9
http://fundanet.fsjd.org/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=11273

Plasma drug concentrations and virologic evaluations after stopping treatment with nonnucleoside reverse-transcriptase inhibitors in HIV type 1-infected children

Autor: Cressey, Tr, Green, H, Khoo, S, Treluyer, Jm, Compagnucci, A, Saidi, Y, Lallemant, M, Gibb, Dm, Burger, Dm, Collaborators: Aboulker JP, Paediatric European Network for Treatment of AIDS II Study G. r. o. u. p., Babiker, A, Blanche, S, Bohlin, Ab, Butler, K, Castelli Gattinara, G, Clayden, P, Darbyshire, Jh, Debré, M, de Groot, R, della Negra, M, Duicelescu, D, Giaquinto, C, Grosch Wörner, I, Kind, C, Levy, J, Lyall, H, Marczynska, M, Mellado Peña MJ, Nadal, D, Niehues, T, Peckham, C, Ramos Amador JT, Rosado, L, Rudin, C, Scherpbier, Hj, Sharland, M, Stevanovic, M, Tovo, Pier Angelo, Tudor Williams, G, Valerius, N, Walker, As, Wintergerst, U, Aboulker, Jp, Harper, L, Klein, N, Mofenson, L, Moye, J, Saïdi, Y, Jacqz Aigrain, E, Tréluyer, Jm, Clerici, M, De Rossi, A, Ngo Giang Huong, N, Muñoz Fernandez MA, Pillay, D, Hill, C, Lepage, P, Pozniak, A, Vella, S, Eliette, V, Hadjou, G, Léonardo, S, Pitrou, C, Riault, Y, Buck, L, Farrelly, L, Johnson, D, Taylor, C, Chalermpantmetagul, S, Peongjakta, R, Chailert, S, Fregonese, F, Jourdain, G, Butler, D, Carlton, C, Collins, D, Kao, G, Van Buskirk, S, Watson, S, Corradini, S, Floret, D, Laplace, J, Monpoux, F, Cottalorda, J, Lefebvre, Jc, Mellul, S, Boudjoudi, N, Firtion, G, Faye, A, Beniken, D, Damond, F, Tricoire, J, Krivine, A, Chaix, Ml, Notheis, G, Strotmann, G, Schlieben, S, Rampon, O, Zanchetta, M, Rosso, R, Repeto, E, Vitale, F, Martino, A, Bernardi, S, Mazza, A, Rossetti, G, Dobosz, S, Oldakowska, A, Popielska, J, Kaflik, M, Stanczak, J, Stanczac, T, González Tomé MI, Delgado García, R, José Mellado Peña, M, Martín Fontelos, P, Piñeiro Pérez, R, Alimenti, A, Penin, M, Gurbindo, D, Navarro Gomez ML, Jimenez, Jl, Prieto, C, de José Gómez MI, García Rodriguez MC, Moreno Pérez, D, Núñéz Cuadros, E, Asensi Botet, F, Pérez, A, Pérez Tamarit MD, Kalhert, C, Schupbach, J, Bunupuradah, T, Ananworanich, J, Phanuphak, P, Intasan, J, Ubolyam, S, Kanjanavanit, S, Namwong, T, Foster, C, Hamadache, D, Campbell, S, Hanley, C, Walsh, C, Kaye, S, Seery, P, Novelli, V, Shingadia, D, Flynn, J, Clapson, M, Jacobsen, M, Mcmaster, P, Hawkes, E, Liebeschuetz, S, Sodeinde, O, Wong, S, Walsh, S, Heath, Y, Weiner, L, Famiglietti, M, Rana, S, Yu, P, Roa, J, Puga, A, Haerry, A, Regazzi, M, Villani, S, Gibbons, S, Jullien, V, Rey, E, Treluye, Jm, Rodríguez Nóvoa, S, Tawon, Y.

Publikováno v: Clinical Infectious Diseases, 46, 1601-8
Clinical Infectious Diseases, 46, 10, pp. 1601-8

Contains fulltext : 71467.pdf (Publisher’s version ) (Open Access) BACKGROUND: The optimum strategy for stopping treatment with drugs that have different half-lives in a combination regimen to minimize the risk of selecting drug-resistant viruses r

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e9428bb7140b14cab2921aa8a80c9159
https://doi.org/10.5167/uzh-12417

Early antiretroviral therapy initiation effect on metabolic profile in vertically HIV-1-infected children.

Autor: Tarancón-Diez L; Molecular Immunology Laboratory, Hospital General Universitario Gregorio Marañón, Health Research Institute Gregorio Marañón (IiSGM), Madrid, Spain., Rull A; Universitat Rovira i Virgili, Tarragona, Spain.; Institut Investigació Sanitària Pere Virgili (IISPV), Tarragona, Spain.; Hospital Universitari de Tarragona Joan XXIII, Tarragona, Spain., Herrero P; Eurecat, Centre Tecnològic de Catalunya, Unitat de Ciències Òmiques (Unitat Mixta de Eurecat-Universitat Rovira i Virgili), Infraestructura Científico-Tècnica Singular (ICTS), Reus, Spain., Vazquez-Alejo E; Molecular Immunology Laboratory, Hospital General Universitario Gregorio Marañón, Health Research Institute Gregorio Marañón (IiSGM), Madrid, Spain., Peraire J; Universitat Rovira i Virgili, Tarragona, Spain.; Institut Investigació Sanitària Pere Virgili (IISPV), Tarragona, Spain.; Hospital Universitari de Tarragona Joan XXIII, Tarragona, Spain., Guillén S; Department of Pediatrics, Hospital Universitario de Getafe, Madrid, Spain., Navarro-Gomez ML; Hospital General Universitario Gregorio Marañón, Health Research Institute Gregorio Marañón (IiSGM), Madrid, Spain., Viladés C; Universitat Rovira i Virgili, Tarragona, Spain.; Institut Investigació Sanitària Pere Virgili (IISPV), Tarragona, Spain.; Hospital Universitari de Tarragona Joan XXIII, Tarragona, Spain., Muñoz-Fernandez MÁ; Molecular Immunology Laboratory, Hospital General Universitario Gregorio Marañón, Health Research Institute Gregorio Marañón (IiSGM), Madrid, Spain.; Spanish HIV-HGM BioBank, Madrid, Spain., Vidal F; Universitat Rovira i Virgili, Tarragona, Spain.; Institut Investigació Sanitària Pere Virgili (IISPV), Tarragona, Spain.; Hospital Universitari de Tarragona Joan XXIII, Tarragona, Spain.

Publikováno v: The Journal of antimicrobial chemotherapy [J Antimicrob Chemother] 2021 Oct 11; Vol. 76 (11), pp. 2993-3001.